The inflammatory response to stent grafting of the thoracic aorta

International Angiology

Volumn 26, Issue 3, 2007, Pages 219-227

  Odegard A ^a   Aasland, J ^a   Myhre, Hans O ^a,b   Mollnes, T E ^c   Videm, V ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aorta, thoracic; Inflammation; Stent

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3BC; INTERCELLULAR ADHESION MOLECULE 1; IOHEXOL; LACTOFERRIN; MYELOPEROXIDASE; NEOPTERIN; NEUTROPHIL ACTIVATING PEPTIDE 2; PEPTIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; AORTA GRAFT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; RADIOGRAPHY; STENT; THORACIC AORTA ANEURYSM; THROMBOCYTE COUNT; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC ANEURYSM, THORACIC; AORTITIS; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; PEROXIDASE; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; STENTS;

EID: 34848887683     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Norwood MGA, Bowm, MJ, Sayers RD. Ischaemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2004;28:234-45.
2. Harward TR, Welborn MB 3rd, Martin TD, Flynn TC, Huber TS, Moldawer LL et al. Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair: A clinical and cost analysis. Ann Surg 1996;223:729-34; discussion 734-6.
3. Coselli JS, LeMaire SA, Conklin LD, Adams GJ. Left heart bypass during descending thoracic aortic aneurysm repair does not reduce the incidence of paraplegia. Ann Thorac Surg 2004;77:1298-303; discussion 1303.
4. Eide TO, Aasland J, Romundstad P, Stenseth R, Saether OD, Aadahl P et al. Changes in hemodynamics and acid-base balance during cross-clamping of the descending thoracic aorta. A study in patients operated on for thoracic and thoracoabdominal aortic aneurysm. Eur Surg Res 2005;37:330-4.
5. Norwood MG, Bown MJ, Sutton AJ, Nicholson ML, Sayers RD. Interleukin 6 production during abdominal aortic aneurysm repair arises from the gastrointestinal tract and not the legs. Br J Surg 2004;91:1153-6.
6. Lau LL, Gardiner KR, Martin L, Halliday MI, Hannon RJT, Lee B et al. Extraperitoneal approach reduces neutrophil activation, systemic inflammatory response and organ dysfunction in aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2001;21:326-33.
7. Bown MJ, Nicholson ML, Bell PR, Sayers RD. Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001;22:485-95.
8. Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, Geiran OR et al. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 2003;108:849-56.
9. Adembri C, Kastamoniti E, Bertolozzi I, Vanni S, Dorigo W, Coppo M et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 2004;32:1170-7.
10. De Mol Van Otterloo JC, Van Bockel JH, Ponfoort ED, Brommer EJ, Hermans J, Daha MR. The effects of aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system. J Vasc Surg 1992;16:774-83.
11. P⊣smson HN. Cellular reactions to vascular implants (Doctoral thesis). Bulletin Dept Surg Lund, Lund, Sweden; 1993.
12. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stentgrafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994;331:1729-34.
13. Leurs LJ, Bell R, Degrieck Y, Thomas S, Hobo R, Lundbom J; EUROSTAR; UK Thoracic Endograft Registry collaborators. Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries. J Vasc Surg 2004;40:670-9; discussion 679-80.
14. Aasland J, Lundbom J, Eide TO, Odegard A, Aadahl P, Romundstad PR et al. Recovery following treatment of descending thoracic aortic disease. A comparison between endovascular repair and open surgery. Int Angiol 2005;24:231-7.
15. Pearson S, Hassen T, Spark JI, Cabot J, Cowled P, Fitridge R. Endovascular repair of abdominal aortic aneurysm reduces intraoperative corlisol and perioperative morbidity. J Vasc Surg 2005;41:919-25.
16. Odegard A, Lundbom J, Myhre HO, Hatlinghus S, Bergh K, Waage A et al. The inflammatory response following treatment of abdominal aortic aneurysms: a comparison between open surgery and endovascular repair. Eur J Vasc Endovasc Surg 2000;19:536-44.
17. Galle C, De Maertelaer V, Motte S, Zhou L, Stordeur P, Delville JP et al. Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. J Vasc Surg 2000;32:234-46.
18. Swartbol P, Truedsson L, Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001;21:393-400.
19. Forester ND, Cruickshank SM, Scott DJ, Carding SR. Functional characterization of T cells in abdominal aortic aneurysms. Immunology 2005;115:262-70.
20. Treska V, Kocova J, Boudova L, Neprasova P, Topolcan O, Pecen L et al. Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell Mol Ther 2002;7:91-7.
21. Pearce WH, Koch AE. Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:175-85.
22. Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 2000;67:591-602.
23. Swartbol P, Truedson L, Norgren L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg 1998;28:664-8.
24. Blann AD, Adams R, Ashleigb R, Naser S, Kirkpatrick U, McCollum CN. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. Br J Radiol 2001;74:811-7.
25. Videm V, Ödegård A, Myhre HO. Iohexol-induced neutrophil myeloperoxidase release and activation upon contact with vascular stent-graft material: a mechanism contributing to the postimplantation syndrome? J Endovasc Ther 2003;10:958-67.
26. Vidern V. Heparin in clinical doses "primes" granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol 1996;43:385-90.
27. Hegnhøj J, Schaffalitzky de Muckadell OB. An enzyme-linked immunosorbent assay for measurement of lactoferrin in duodenal aspirates and other biological fluids. Scand J Clin Lab Invest 1985;45:489-95.
28. Mollnes TE. Analysis of in vivo complement activation. In: Herzenberg LA, Weir DM, Herzenberg LA, Blackwell C, editors. Weir's handbook of experimental immunology. 5th ed. Boston: Blackwell Science; 1997.p.78.1-78.8.
29. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997;17:2843-7.
30. Nomura F, Ihara A, Yoshitatsu M, Tamura K, Katayama A, Ihara K. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg 2003;23:1034-8; discussion 1038-9.
31. Nambi V. The use of myeloperoxidase as a risk marker for atherosclerosis. Curr Atheroscler Rep 2005;7:127-31.
32. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
33. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG. Inflammation and atherosclerosis. Eur J Vasc Endovasc Surg 2006;31:386-93.
34. Eikemo H, Sellevold OF, Videm V. Markers for endothelial activation during open heart surgery. Ann Thorac Surg 2004;77:214-9.
35. Videm V, Mollnes TE, Bergh K, Fosse E, Mohr B, Hagve TA et al. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg 1999;117:803-9.